Harbor review
Each plan states what it covers. Each figure carries the word from.
The verdict
Harbor publishes from $99 a month for compounded semaglutide and from $149 for tirzepatide, read August 2026. Each plan covers medication, provider consultations, refill management and shipping.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- $99/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Harbor sells both molecules as a weekly injection. Each figure is bundled. Four things are named as included.
Who writes the prescription, and what do they see?
Provider consultations are named as included in both plans. No clinician is described. The intake is not documented.
Naming four inclusions is a real disclosure. Refill management is unusual to see itemized. What the word from does to all of it is the offsetting problem.
What happens when the dose goes up?
Nothing is published about dose. A bundled floor with no milligram attached cannot be compared against a rate that carries one. The inclusions are stated; the dose is not.
What the price includes
$99 and $149 are floors rather than rates. Six months at them is $594 and $894 at best. What raises them is not published. Ask for the figure at a therapeutic dose before ordering.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: Four inclusions named in each plan
- Strength: Refill management itemized explicitly
- Strength: Both molecules carry a figure
- Limitation: Both figures are a floor, not a rate
- Limitation: No milligram dose stated anywhere
- Limitation: No state coverage list is recorded
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about Harbor. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who values a bundled plan and will ask what raises the floor.
- Wrong for
- A reader budgeting six months from $99.
How Harbor compares
| Seller | Who it suits | Go |
|---|---|---|
| Green Cap Health | Readers in Texas wanting the lowest published figures | See Green Cap Health → |
 Glam Health | Readers who will ask what the plan costs at their own dose | See Glam Health → |
 Get Thin MD | Readers taking the three-month plan who read what the sale actually covers | See Get Thin MD → |
More GLP-1 telehealth sellers reviews: NuBloomNucore HealthNuDay RxNuvaHealthOakObu Health
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- What is included?
- Medication, provider consultations, refill management and shipping, named in both plans.
- Is $99 a rate?
- No. It is a floor. Both figures carry the word from and what raises them is not published.
- What dose does it cover?
- No milligram figure is published beside either price.
- Is Harbor expensive compared with other GLP-1 telehealth sellers?
- Harbor publishes a starting figure of $99/mo. Across the 112 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $179, which puts Harbor below the median, toward the cheaper end. The other 8 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.